valproic acid has been researched along with Impaired Glucose Tolerance in 3 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with COC led to elevated fasting blood glucose, insulin, corticosterone, triglycerides (TG), TG/HDL-cholesterol ratio, insulin resistance (IR) and impaired glucose tolerance." | 7.83 | Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone. ( Kim, I; Olatunji, LA; Omolekulo, TE; Usman, TO, 2016) |
"Treatment with COC led to elevated fasting blood glucose, insulin, corticosterone, triglycerides (TG), TG/HDL-cholesterol ratio, insulin resistance (IR) and impaired glucose tolerance." | 3.83 | Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone. ( Kim, I; Olatunji, LA; Omolekulo, TE; Usman, TO, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Adegoke, TE | 1 |
Sabinari, IW | 1 |
Usman, TO | 2 |
Abdulkareem, TO | 1 |
Michael, OS | 1 |
Adeyanju, OA | 1 |
Dibia, C | 1 |
Omotoye, OO | 1 |
Oyabambi, AO | 1 |
Olatunji, LA | 2 |
Omolekulo, TE | 1 |
Kim, I | 1 |
Verrotti, A | 1 |
Manco, R | 1 |
Agostinelli, S | 1 |
Coppola, G | 1 |
Chiarelli, F | 1 |
3 other studies available for valproic acid and Impaired Glucose Tolerance
Article | Year |
---|---|
Allopurinol and valproic acid improve cardiac triglyceride and Na
Topics: Adenosine Triphosphatases; Aldosterone; Allopurinol; Animals; Contraceptives, Oral, Combined; Female | 2022 |
Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone.
Topics: Animals; Anticonvulsants; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Female; Glu | 2016 |
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
Topics: Adolescent; Anticonvulsants; Body Mass Index; Cardiovascular Diseases; Child; Comorbidity; Dyslipide | 2010 |